These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28177312)

  • 1. Ligand fitting with CCP4.
    Nicholls RA
    Acta Crystallogr D Struct Biol; 2017 Feb; 73(Pt 2):158-170. PubMed ID: 28177312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tools for ligand validation in Coot.
    Emsley P
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):203-210. PubMed ID: 28291755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AceDRG: a stereochemical description generator for ligands.
    Long F; Nicholls RA; Emsley P; Graǽulis S; Merkys A; Vaitkus A; Murshudov GN
    Acta Crystallogr D Struct Biol; 2017 Feb; 73(Pt 2):112-122. PubMed ID: 28177307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling covalent linkages in CCP4.
    Nicholls RA; Joosten RP; Long F; Wojdyr M; Lebedev A; Krissinel E; Catapano L; Fischer M; Emsley P; Murshudov GN
    Acta Crystallogr D Struct Biol; 2021 Jun; 77(Pt 6):712-726. PubMed ID: 34076587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using more than 801 296 small-molecule crystal structures to aid in protein structure refinement and analysis.
    Cole JC; Giangreco I; Groom CR
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):234-239. PubMed ID: 28291758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the protein-ligand interaction energy for model building and validation.
    Beshnova DA; Pereira J; Lamzin VS
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):195-202. PubMed ID: 28291754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of small-molecule structures to complement protein-ligand crystal structures in drug discovery.
    Groom CR; Cole JC
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):240-245. PubMed ID: 28291759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twilight reloaded: the peptide experience.
    Weichenberger CX; Pozharski E; Rupp B
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):211-222. PubMed ID: 28291756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Protein-Ligand Crystal Structure Models: Small Molecule and Peptide Ligands.
    Pozharski E; Deller MC; Rupp B
    Methods Mol Biol; 2017; 1607():611-625. PubMed ID: 28573591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput quantum-mechanics/molecular-mechanics (ONIOM) macromolecular crystallographic refinement with PHENIX/DivCon: the impact of mixed Hamiltonian methods on ligand and protein structure.
    Borbulevych O; Martin RI; Westerhoff LM
    Acta Crystallogr D Struct Biol; 2018 Nov; 74(Pt 11):1063-1077. PubMed ID: 30387765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The critical role of QM/MM X-ray refinement and accurate tautomer/protomer determination in structure-based drug design.
    Borbulevych OY; Martin RI; Westerhoff LM
    J Comput Aided Mol Des; 2021 Apr; 35(4):433-451. PubMed ID: 33108589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved ligand geometries in crystallographic refinement using AFITT in PHENIX.
    Janowski PA; Moriarty NW; Kelley BP; Case DA; York DM; Adams PD; Warren GL
    Acta Crystallogr D Struct Biol; 2016 Sep; 72(Pt 9):1062-72. PubMed ID: 27599738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCP4i2: the new graphical user interface to the CCP4 program suite.
    Potterton L; Agirre J; Ballard C; Cowtan K; Dodson E; Evans PR; Jenkins HT; Keegan R; Krissinel E; Stevenson K; Lebedev A; McNicholas SJ; Nicholls RA; Noble M; Pannu NS; Roth C; Sheldrick G; Skubak P; Turkenburg J; Uski V; von Delft F; Waterman D; Wilson K; Winn M; Wojdyr M
    Acta Crystallogr D Struct Biol; 2018 Feb; 74(Pt 2):68-84. PubMed ID: 29533233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
    Halder AK; Saha A; Saha KD; Jha T
    J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models of protein-ligand crystal structures: trust, but verify.
    Deller MC; Rupp B
    J Comput Aided Mol Des; 2015 Sep; 29(9):817-36. PubMed ID: 25665575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a Selective Allosteric Inhibitor Targeting Macrodomain 2 of Polyadenosine-Diphosphate-Ribose Polymerase 14.
    Schuller M; Riedel K; Gibbs-Seymour I; Uth K; Sieg C; Gehring AP; Ahel I; Bracher F; Kessler BM; Elkins JM; Knapp S
    ACS Chem Biol; 2017 Nov; 12(11):2866-2874. PubMed ID: 28991428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging Crystal Engineering and Drug Discovery by Utilizing Intermolecular Interactions and Molecular Shapes in Crystals.
    Spackman PR; Yu LJ; Morton CJ; Parker MW; Bond CS; Spackman MA; Jayatilaka D; Thomas SP
    Angew Chem Int Ed Engl; 2019 Nov; 58(47):16780-16784. PubMed ID: 31385643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free energy calculation provides insight into the action mechanism of selective PARP-1 inhibitor.
    Cao R
    J Mol Model; 2016 Apr; 22(4):74. PubMed ID: 26969680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3.
    Lehtiö L; Jemth AS; Collins R; Loseva O; Johansson A; Markova N; Hammarström M; Flores A; Holmberg-Schiavone L; Weigelt J; Helleday T; Schüler H; Karlberg T
    J Med Chem; 2009 May; 52(9):3108-11. PubMed ID: 19354255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Techniques, tools and best practices for ligand electron-density analysis and results from their application to deposited crystal structures.
    Pozharski E; Weichenberger CX; Rupp B
    Acta Crystallogr D Biol Crystallogr; 2013 Feb; 69(Pt 2):150-67. PubMed ID: 23385452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.